Discovery and clinical progression of highly selective M1 agonists utilizing structure-based drug design

被引：0
|
作者：
Brown, Giles [1 ]
机构：
[1] Heptares Therapeut Ltd, Cambrdige, England
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 254卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
244
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Structure-based Ligand Design and the Promise Held for Antiprotozoan Drug Discovery
    Hunter, William N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (18) : 11749 - 11753
  • [32] The role of structure-based ligand design and molecular modelling in drug discovery
    Tollenaere, JP
    PHARMACY WORLD & SCIENCE, 1996, 18 (02): : 56 - 62
  • [33] Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design
    Han, Wooseok
    Ding, Yu
    Xu, Yongjin
    Pfister, Keith
    Zhu, Shejin
    Warne, Bob
    Doyle, Mike
    Aikawa, Mina
    Amiri, Payman
    Appleton, Brent
    Stuart, Darrin D.
    Fanidi, Abdallah
    Shafer, Cynthia M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (07) : 3034 - 3045
  • [34] Structure-Based Design, Synthesis, and In Vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists
    Petrelli, Riccardo
    Scortichini, Mirko
    Belardo, Carmela
    Boccella, Serena
    Luongo, Livio
    Capone, Fabio
    Kachler, Sonja
    Vita, Patrizia
    Del Bello, Fabio
    Maione, Sabatino
    Lavecchia, Antonio
    Klotz, Karl-Norbert
    Cappellacci, Loredana
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (01) : 305 - 318
  • [35] Cabergoline and IOP: implications for structure-based drug discovery of selective dopaminergic ligands
    Drago, Filippo
    Platania, Chiara Bianca Maria
    Marrazzo, Giuseppina
    Leggio, Gian Marco
    Bucolo, Claudio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [36] Structure-based design, synthesis by click chemistry and in vivo activity of highly selective A3 adenosine receptor agonists
    Tosh, Dilip K.
    Paoletta, Silvia
    Chen, Zhoumou
    Crane, Steven
    Lloyd, John
    Gao, Zhan-Guo
    Gizewski, Elizabeth T.
    Auchampach, John A.
    Salvemini, Daniela
    Jacobson, Kenneth A.
    MEDCHEMCOMM, 2015, 6 (04) : 555 - 563
  • [37] The integration of structure-based drug design & combinatorial chemistry for efficient drug discovery.
    Salemme, FR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 187 - COMP
  • [38] Discovery and optimization of highly ligand-efficient oxytocin receptor antagonists using structure-based drug design
    Bellenie, Benjamin R.
    Barton, Nicholas P.
    Emmons, Amanda J.
    Heer, Jag P.
    Salvagno, Cristian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 990 - 994
  • [39] Structure-based drug design with PDK1.
    van Aalten, DMF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U438 - U438
  • [40] Structure-based drug design utilizing halogen bonding: Factor Xa inhibitors
    Lam, Patrick Y. S.
    Clark, Charles G.
    Smallwood, Angela M.
    Alexander, Richard S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
12345